论文部分内容阅读
目的探讨胸腺肽、补金片与抗肺结核药物治疗复治肺结核的临床疗效。方法选择85例复治肺结核患者,随机分成治疗组(43例)和对照组(42例)。治疗组在应用抗肺结核药物基础上加用胸腺肽,补金片治疗3个月,观察患者治疗结果。结果治疗组患者自觉症状、痰菌阴转率、细胞免疫、胸片各指标与照组对比有明显差异(P<0.05),且无明显副作用。结论抗肺结核药物加胸腺肽、补金片治疗复制结核患者疗效显著,总有效率为95%。
Objective To investigate the clinical efficacy of thymosin, patch and anti-tuberculosis drugs in the treatment of retreatment tuberculosis. Methods Eighty-five retreatment tuberculosis patients were randomly divided into treatment group (43 cases) and control group (42 cases). Treatment group in the application of anti-tuberculosis drugs based on the use of thymosin, gold tablets for 3 months, observe the results of treatment of patients. Results There were significant differences (P <0.05) between the index of symptoms and sputum negative conversion rate, cellular immunity and chest radiograph in treatment group and no significant side effects. Conclusion The anti-tuberculosis drugs plus thymosin, gold tablets treatment of patients with replication of tuberculosis significant effect, the total effective rate was 95%.